ArticleLeukemia2019
Histone deacetylase inhibitor targets CD123/CD47-positive cells and reverse chemoresistance phenotype in acute myeloid leukemia.
Bowen Yan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this papertrialcites it